Related Experiment Video
Updated: May 24, 2025

Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
Published on: December 24, 2015
Replicative senescence in amniotic fluid-derived mesenchymal stem cells and its impact on their immunomodulatory
Elham Zare1,2, Elham Sadat Hosseini3, Faezeh Sadat Azad2
1Medical Genetics and Molecular Medicine Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
The expansion of mesenchymal stem cells (MSCs) for clinical applications is often limited by replicative senescence, a growth arrest induced by various stresses during in vitro culture, yet its impact on the immunomodulatory properties of MSCs remains unclear. This study derived MSCs from the amniotic fluid (AF-MSCs) of seven first-trimester pregnancies, characterized them through flow cytometry, and evaluated their osteogenic differentiation potential before expanding the cells to compare immunoregulatory gene expression in proliferative and senescent states. Additionally, an assessment of the adipogenic differentiation potential of AF-MSCs from three samples was conducted following their recovery from approximately 9 months of cryopreservation, with results showing that these recovered cells retain the capacity for adipogenic differentiation. Molecular analysis revealed no significant differences in the expression of key immunoregulatory genes, such as TGFβ, IL-10, IDO, and VCAM-1, between proliferative and senescent cells, although senescent cells showed downregulation of FASL and upregulation of IL-6, COX1, and HLA-G. Markers of cell proliferation, including FOXM1 and B-MYB, were significantly downregulated in senescent cells, confirming the progression of replicative senescence. Despite expectations, the results indicated that some immunomodulatory markers remained stable or were even enhanced in senescent AF-MSCs. These findings highlight the resilience of AF-MSC immunomodulatory properties during prolonged in vitro expansion, supporting their potential for therapeutic applications despite the challenges posed by replicative senescence.
Insights
Replicative senescence does not significantly impair the immunomodulatory properties of amniotic fluid-derived mesenchymal stem cells (AF-MSCs). Senescent AF-MSCs retain therapeutic potential, showing resilience in key immune gene expression despite prolonged culture.
Area of Science:
- Stem Cell Biology
- Immunology
- Regenerative Medicine
Background:
- Mesenchymal stem cells (MSCs) are crucial for regenerative medicine but their clinical use is limited by replicative senescence during in vitro expansion.
- The effect of senescence on the immunomodulatory capacity of MSCs, particularly those derived from amniotic fluid (AF-MSCs), is not well understood.
Purpose of the Study:
- To investigate the impact of replicative senescence on the immunomodulatory gene expression of AF-MSCs.
- To assess the differentiation potential and immunomodulatory stability of AF-MSCs after prolonged culture and cryopreservation.
Main Methods:
- AF-MSCs were derived from first-trimester amniotic fluid and characterized by flow cytometry.
- Osteogenic and adipogenic differentiation potentials were evaluated.
- Immunoregulatory gene expression (TGFβ, IL-10, IDO, VCAM-1, FASL, IL-6, COX1, HLA-G) was compared between proliferative and senescent AF-MSCs.
- Cell proliferation markers (FOXM1, B-MYB) were assessed.
Main Results:
- Senescent AF-MSCs maintained adipogenic differentiation capacity after cryopreservation.
- Key immunomodulatory genes (TGFβ, IL-10, IDO, VCAM-1) showed no significant difference between proliferative and senescent cells.
- Senescent cells exhibited downregulation of FASL and upregulation of IL-6, COX1, and HLA-G.
- Cell proliferation markers FOXM1 and B-MYB were significantly downregulated in senescent cells.
Conclusions:
- AF-MSCs demonstrate resilience in their immunomodulatory properties despite replicative senescence.
- Senescence does not abrogate the potential therapeutic applications of AF-MSCs.
- These findings support the use of AF-MSCs in clinical settings, even after extended in vitro culture.
Related Concept Videos
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells
Adult Stem Cells
iPS Cell Differentiation
Replicative Cell Senescence
Stem Cell Niche

